AKBA vs AMPH: Side-by-Side Comparison
Compare Akebia Therapeutics Inc (AKBA) and Amphastar Pharmaceuticals Inc (AMPH) side by side: market cap USD 332.64M vs USD 865.98M. Financials, growth and model signals on Bullrun.
| Metric | AKBA | AMPH |
|---|---|---|
| Company | Akebia Therapeutics Inc | Amphastar Pharmaceuticals Inc |
| Country / Exchange | United States · NASDAQ | United States · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers-Specialty & Generic | Drug Manufacturers-Specialty & Generic |
| Market cap | USD 332.64M | USD 865.98M |
| P/E ratio | — | 11.8 |
| Dividend yield | — | — |
| Valuation model | — | 49.7% undervalued |
| Revenue (FY2025) | USD 236.20M | USD 719.89M |
| Revenue growth YoY | +47.5% | -1.7% |
| Net income | USD -5.30M | USD 98.09M |
| Gross margin | 83.3% | 49.5% |
| Diluted EPS | -0.02 | 2.03 |